Tulsa Cancer Institute PLLC is a clinical research site located in Tulsa, Oklahoma, United States.
Crixeo Clinical Trials Trust Score: 12/100 (FAILING). This profile has not yet been claimed by the site owner.
Tulsa Cancer Institute PLLC has participated in 4 clinical trials.
Therapeutic areas: Pancreatic Cancer, Melanoma, Malignant Melanoma.
Sponsors: Merrimack Pharmaceuticals, Pfizer, Bristol-Myers Squibb.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Oklahoma · View every site in Tulsa
Trust Score: 12/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Tulsa Cancer Institute PLLC has a Crixeo Trust Score of 12/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Tulsa Cancer Institute PLLC has 4 clinical trials on record. Their work covers Pancreatic Cancer, Melanoma, Malignant Melanoma.
Tulsa Cancer Institute PLLC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.